Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calvin R Sumner

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Psychiatric Practice|September 7, 2023
Psychedelics, With a Focus on Psilocybin: Issues for the ClinicianAmir Garakani, Jeanne L Alexander, Calvin R Sumner, et al.
Current Psychiatry Reports|May 2, 2024
Vitamin B<sub>12</sub> Supplementation in Psychiatric PracticeKevin P Kennedy, Jeanne L Alexander, Amir Garakani, et al.
Pediatrics|July 3, 2004
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trialDouglas K Kelsey, Calvin R Sumner, Charles D Casat, et al.
Journal of Child and Adolescent Psychopharmacology|September 8, 2007
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression, Mark E Bangs, Graham J Emslie, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Psychiatric Practice|September 7, 2023
Psychedelics, With a Focus on Psilocybin: Issues for the ClinicianAmir Garakani, Jeanne L Alexander, Calvin R Sumner, et al.
Current Psychiatry Reports|May 2, 2024
Vitamin B<sub>12</sub> Supplementation in Psychiatric PracticeKevin P Kennedy, Jeanne L Alexander, Amir Garakani, et al.
Pediatrics|July 3, 2004
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trialDouglas K Kelsey, Calvin R Sumner, Charles D Casat, et al.
Journal of Child and Adolescent Psychopharmacology|September 8, 2007
Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression, Mark E Bangs, Graham J Emslie, et al.
Pageof 2